Cognitive/neurodegenerative disorders: Phase II trials

Low-Dose Lithium for the Treatment of Behavioral Symptoms in Frontotemporal Dementia (Lithium)

Lithium carbonate

Phase II

Frontotemporal dementia (FTD)

United States

Ongoing, not yet recruiting

https://clinicaltrials.gov/ct2/show/NCT02862210?term=neurodegenerative&rcv_s=07%2F25%2F2016&rcv_e=08%2F25%2F2016&lup_s=07%2F25%2F2016&lup_e=08%2F25%2F2016&rank=4


Conversations as a Means to Delay Alzheimer's Disease (AD) Onset (CESII)

Conversational Engagement

Phase II

Alzheimers disease

United States

Ongoing, not yet recruiting

https://clinicaltrials.gov/ct2/show/NCT02871921?term=neurodegenerative&rcv_s=07%2F25%2F2016&rcv_e=08%2F25%2F2016&lup_s=07%2F25%2F2016&lup_e=08%2F25%2F2016&rank=18


Open-label Study of Nelotanserin in Lewy Body Dementia With Visual Hallucinations or REM Sleep Behavior Disorder

Nelotanserin

Phase II

Dementia; Parkinsons; hallucinations; sleep behaviour disorder

United States

Recruiting (invitation only)

https://clinicaltrials.gov/ct2/show/NCT02871427?term=sleep&rcv_s=07%2F25%2F2016&rcv_e=08%2F25%2F2016&lup_s=07%2F25%2F2016&lup_e=08%2F25%2F2016&rank=3


Perfusion by Arterial Spin Labelling Following Single Dose Tadalafil in Small Vessel Disease (PASTIS) Trial

Tadalafil

Phase II

Vascular dementia

UK

Recruiting

Click here for further information


DAOIB for the Treatment of Cognitive Function and Behavioral and Psychological Symptoms of Dementia

DAOIB

Phase II

Behavioral and Psychological Symptoms in Alzheimer's Disease & Vascular Dementia

Taiwan

Recruiting

Click here for further information


n-3 PUFA for Vascular Cognitive Aging

Omega 3 PUFA

Phase II

Age Related Cognitive Decline; Alzheimer's Disease; Vascular Dementia

USA

Recruiting

Click here for further information


Symptomatic Treatment of Vascular Cognitive Impairment (STREAM-VCI)

Galantamine; Methylphenidate

Phase II

Mild Cognitive Impairment (Vascular); Mild Cognitive Disorder (Vascular); Vascular Dementia

Recruiting

Click here for further information


Effect of Insulin Sensitizer Metformin on AD Biomarkers

Metformin

Phase II

Alzheimer's Disease; Vascular Dementia; Dementia

USA

Recruiting

Click here for further information


Safety Study of Dabigatran in CADASIL

Dabigatran; Antiplatelets

Phase II

CADASIL

Italy

Recruiting

Click here for further information


A Phase 2, to Evaluating the Safety and Efficacy of Pridopidine Versus Placebo for Symptomatic Treatment in Patients With Huntington's Disease

Pridopidine

Phase II

Multiple worldwide locations

Recruiting

Click here for further information


Phase IIb Study of Intranasal Glutathione in Parkinson's Disease ((in)GSH)

Reduced Glutathione

Phase II

United States

Recruiting

Click here for further information


Randomised Crossover Trial of Deep Brain Stimulation of Differential Posterior Subthalamic Area Regions in Parkinson's Disease and Tremor

Up to 3 mA, 60 us, 130 Hz deep brain stimulation, Empirical unblinded deep brain stimulation programming

Phase II

Australia

Recruiting

Click here for further information


Study of the Safety & Efficacy of Leukine® in the Treatment of Alzheimer's Disease

Sagramostim

Phase II

United States

Recruiting

Click here for further information


Efficacy of L-threo DOPS on Orthostatic Hypotension Symptoms and Other Non-motor Symptoms in Patients With MSA (DOPS-AMS)

L-Threo DOPS

Phase II

France

Recruiting

Click here for further information


Treatment of Parkinson Disease and Multiple System Atrophy Using Intranasal Insulin

Intranasal Insulin

Phase II

United States

Recruiting

Click here for further information


n-3 PUFA for Vascular Cognitive Aging

Omega 3 PUFA

Phase II

United States

Recruiting

Click here for further information